A Genome-Wide Association Study Identifies Novel Risk Loci for Sarcopenia in a Taiwanese Population

References

• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169
   PubMed Web of Science ®Google Scholar
• Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548. doi:10.1371/journal.pone.0169548
   PubMed Web of Science ®Google Scholar
• Zhang H, Lin S, Gao T, et al. Association between sarcopenia and metabolic syndrome in middle-aged and older non-obese adults: a systematic review and meta-analysis. Nutrients. 2018;10(3):364. doi:10.3390/nu10030364
   PubMed Web of Science ®Google Scholar
• Kim SH, Jeong JB, Kang J, et al. Association between sarcopenia level and metabolic syndrome. PLoS One. 2021;16(3):e0248856. doi:10.1371/journal.pone.0248856
   PubMed Web of Science ®Google Scholar
• Gianoudis J, Bailey CA, Daly RM. Associations between sedentary behaviour and body composition, muscle function and sarcopenia in community-dwelling older adults. Osteoporos Int. 2015;26(2):571–579. doi:10.1007/s00198-014-2895-y
   PubMed Web of Science ®Google Scholar
• Messier V, Rabasa-Lhoret R, Barbat-Artigas S, Elisha B, Karelis AD, Aubertin-Leheudre M. Menopause and sarcopenia: a potential role for sex hormones. Maturitas. 2011;68(4):331–336. doi:10.1016/j.maturitas.2011.01.014
   PubMed Web of Science ®Google Scholar
• Pereira RA, Cordeiro AC, Avesani CM, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant. 2015;30(10):1718–1725. doi:10.1093/ndt/gfv133
   PubMed Web of Science ®Google Scholar
• Umegaki H. Sarcopenia and diabetes: hyperglycemia is a risk factor for age-associated muscle mass and functional reduction. J Diabetes Investig. 2015;6(6):623–624. doi:10.1111/jdi.12365
   PubMed Web of Science ®Google Scholar
• Cesari M, Kritchevsky SB, Baumgartner RN, et al. Sarcopenia, obesity, and inflammation–results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am J Clin Nutr. 2005;82(2):428–434. doi:10.1093/ajcn.82.2.428
   PubMed Web of Science ®Google Scholar
• Meng SJ, Yu LJ. Oxidative stress, molecular inflammation and sarcopenia. Int J Mol Sci. 2010;11(4):1509–1526. doi:10.3390/ijms11041509
   PubMed Web of Science ®Google Scholar
• Tan LJ, Liu S-L, Lei SF, Papasian CJ, Deng HW. Molecular genetic studies of gene identification for sarcopenia. Hum Genet. 2012;131(1):1–31. doi:10.1007/s00439-011-1040-7
   PubMed Web of Science ®Google Scholar
• Ran S, He X, Jiang ZX, et al. Whole-exome sequencing and genome-wide association studies identify novel sarcopenia risk genes in Han Chinese. Mol Genet Genomic Med. 2020;8(8):e1267. doi:10.1002/mgg3.1267
   PubMed Web of Science ®Google Scholar
• Singh AN, Gasman B. Disentangling the genetics of sarcopenia: prioritization of NUDT3 and KLF5 as genes for lean mass & HLA-DQB1-AS1 for hand grip strength with the associated enhancing SNPs & a scoring system. BMC Med Genet. 2020;21(1):40. doi:10.1186/s12881-020-0977-6
   PubMed Web of Science ®Google Scholar
• Khanal P, He L, Stebbings G, et al. Prevalence and association of single nucleotide polymorphisms with sarcopenia in older women depends on definition. Sci Rep. 2020;10(1):2913. doi:10.1038/s41598-020-59722-9
   PubMed Web of Science ®Google Scholar
• Sinica A. Taiwan precision medicine initiative. Available from: https://tpmi.ibms.sinica.edu.tw/www/en/. Accessed January 23, 2021.
   Google Scholar
• Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. doi:10.1016/j.jamda.2019.12.012
   PubMed Web of Science ®Google Scholar
• Lonsdale J, Thomas J, Salvatore M. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580–585. doi:10.1038/ng.2653
   PubMed Web of Science ®Google Scholar
• Pe’er I, Yelensky R, Altshuler D, Daly MJ. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol. 2008;32(4):381–385. doi:10.1002/gepi.20303
   PubMed Web of Science ®Google Scholar
• Dudbridge F, Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet Epidemiol. 2008;32(3):227–234. doi:10.1002/gepi.20297
   PubMed Web of Science ®Google Scholar
• Kathiresan S, Melander O, Anevski D, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008;358(12):1240–1249. doi:10.1056/NEJMoa0706728
   PubMed Web of Science ®Google Scholar
• Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337(6099):1190–1195. doi:10.1126/science.1222794
   PubMed Web of Science ®Google Scholar
• Brodie A, Azaria JR, Ofran Y. How far from the SNP may the causative genes be? Nucleic Acids Res. 2016;44(13):6046–6054. doi:10.1093/nar/gkw500
   PubMed Web of Science ®Google Scholar
• Wang K, Li M, Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet. 2007;81(6):1278–1283. doi:10.1086/522374
   PubMed Web of Science ®Google Scholar
• Zillikens MC, Demissie S, Hsu YH, et al. Large meta-analysis of genome-wide association studies identifies five loci for lean body mass. Nat Commun. 2017;8(1):80. doi:10.1038/s41467-017-00031-7
   PubMedGoogle Scholar
• Rappaport N, Nativ N, Stelzer G, et al. MalaCards: an integrated compendium for diseases and their annotation. Database. 2013;2013:bat018. doi:10.1093/database/bat018
   PubMedGoogle Scholar
• Safran M, Dalah I, Alexander J, et al. GeneCards Version 3: the human gene integrator. Database. 2010;2010:baq020. doi:10.1093/database/baq020
   PubMedGoogle Scholar
• Howe KL, Achuthan P, Allen J, et al. Ensembl 2021. Nucleic Acids Res. 2021;49(D1):D884–D891. doi:10.1093/nar/gkaa942
   Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–d613. doi:10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Wang C, JeBailey L, Ridgway ND. Oxysterol-binding-protein (OSBP)-related protein 4 binds 25-hydroxycholesterol and interacts with vimentin intermediate filaments. Biochem J. 2002;361(Pt3):461–472. doi:10.1042/0264-6021:3610461
   PubMedGoogle Scholar
• Consortium U. UniProt: a hub for protein information. Nucleic Acids Res. 2015;43(D1):D204–D212.
   PubMed Web of Science ®Google Scholar
• Poli G, Biasi F, Leonarduzzi G. Oxysterols in the pathogenesis of major chronic diseases. Redox Biol. 2013;1(1):125–130. doi:10.1016/j.redox.2012.12.001
   PubMed Web of Science ®Google Scholar
• Bellanti F, Romano AD, Lo Buglio A, et al. Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity. Maturitas. 2018;109:6–12. doi:10.1016/j.maturitas.2017.12.002
   PubMed Web of Science ®Google Scholar
• Xu R, Wang K, Mileva I, Hannun YA, Obeid LM, Mao C. Alkaline ceramidase 2 and its bioactive product sphingosine are novel regulators of the DNA damage response. Oncotarget. 2016;7(14):18440–18457. doi:10.18632/oncotarget.7825
   PubMedGoogle Scholar
• Wang Y, Zhang C, Jin Y, et al. Alkaline ceramidase 2 is a novel direct target of p53 and induces autophagy and apoptosis through ROS generation. Sci Rep. 2017;7(1):44573. doi:10.1038/srep44573
   PubMedGoogle Scholar
• Liu B, Xiao J, Dong M, Qiu Z, Jin J. Human alkaline ceramidase 2 promotes the growth, invasion, and migration of hepatocellular carcinoma cells via sphingomyelin phosphodiesterase acid-like 3B. Cancer Sci. 2020;111(7):2259–2274. doi:10.1111/cas.14453
   PubMed Web of Science ®Google Scholar
• Mao Z, Sun W, Xu R, et al. Alkaline ceramidase 2 (ACER2) and its product dihydrosphingosine mediate the cytotoxicity of N-(4-hydroxyphenyl)retinamide in tumor cells. J Biol Chem. 2010;285(38):29078–29090. doi:10.1074/jbc.M110.105296
   PubMed Web of Science ®Google Scholar
• Marzetti E, Leeuwenburgh C. Skeletal muscle apoptosis, sarcopenia and frailty at old age. Exp Gerontol. 2006;41(12):1234–1238. doi:10.1016/j.exger.2006.08.011
   PubMed Web of Science ®Google Scholar
• Dupont-Versteegden EE. Apoptosis in muscle atrophy: relevance to sarcopenia. Exp Gerontol. 2005;40(6):473–481. doi:10.1016/j.exger.2005.04.003
   PubMed Web of Science ®Google Scholar
• Kang N, Koo J. Olfactory receptors in non-chemosensory tissues. BMB Rep. 2012;45(11):612–622. doi:10.5483/bmbrep.2012.45.11.232
   PubMed Web of Science ®Google Scholar
• Griffin CA, Kafadar KA, Pavlath GK. MOR23 promotes muscle regeneration and regulates cell adhesion and migration. Dev Cell. 2009;17(5):649–661. doi:10.1016/j.devcel.2009.09.004
   PubMed Web of Science ®Google Scholar
• Tong T, Kim M, Park T. α-Cedrene, a newly identified ligand of MOR23, increases skeletal muscle mass and strength. Mol Nutr Food Res. 2018;62(15):e1800173. doi:10.1002/mnfr.201800173
   PubMed Web of Science ®Google Scholar
• Pichavant C, Burkholder TJ, Pavlath GK. Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress. Skelet Muscle. 2016;6(1):2. doi:10.1186/s13395-016-0077-7
   PubMedGoogle Scholar
• Agostini S, Mancuso R, Costa AS, et al. Sarcopenia associates with SNAP-25 SNPs and a miRNAs profile which is modulated by structured rehabilitation treatment. J Transl Med. 2021;19(1):315. doi:10.1186/s12967-021-02989-x
   PubMed Web of Science ®Google Scholar
• Arden NK, Spector TD. Genetic influences on muscle strength, lean body mass, and bone mineral density: a twin study. J Bone Miner Res. 1997;12(12):2076–2081. doi:10.1359/jbmr.1997.12.12.2076
   PubMed Web of Science ®Google Scholar
• Frederiksen H, Gaist D, Petersen HC, et al. Hand grip strength: a phenotype suitable for identifying genetic variants affecting mid- and late-life physical functioning. Genet Epidemiol. 2002;23(2):110–122. doi:10.1002/gepi.1127
   PubMed Web of Science ®Google Scholar
• Huygens W, Thomis MA, Peeters MW, et al. Linkage of myostatin pathway genes with knee strength in humans. Physiol Genomics. 2004;17(3):264–270. doi:10.1152/physiolgenomics.00224.2003
   PubMed Web of Science ®Google Scholar
• Tiainen K, Sipilä S, Alen M, et al. Heritability of maximal isometric muscle strength in older female twins. J Appl Physiol. 2004;96(1):173–180. doi:10.1152/japplphysiol.00200.2003
   PubMed Web of Science ®Google Scholar
• Zhai G, Ding C, Stankovich J, Cicuttini F, Jones G. The genetic contribution to longitudinal changes in knee structure and muscle strength: a sibpair study. Arthritis Rheum. 2005;52(9):2830–2834. doi:10.1002/art.21267
   PubMedGoogle Scholar
• He L, Khanal P, Morse CI, Williams A, Thomis M. Associations of combined genetic and epigenetic scores with muscle size and muscle strength: a pilot study in older women. J Cachexia Sarcopenia Muscle. 2020;11(6):1548–1561. doi:10.1002/jcsm.12585
   PubMed Web of Science ®Google Scholar
• Urzi F, Pokorny B, Buzan E. Pilot study on genetic associations with age-related sarcopenia. Front Genet. 2020;11:1754.
   Web of Science ®Google Scholar
• Buckinx F, Landi F, Cesari M, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle. 2018;9(2):269–278. doi:10.1002/jcsm.12268
   PubMed Web of Science ®Google Scholar
• Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr. 2002;76(2):378–383. doi:10.1093/ajcn/76.2.378
   PubMed Web of Science ®Google Scholar